EGFR and non-small cell lung carcinoma: It is well-established that EGFR overexpression and abnormal activation is a dominant oncogenic signal for the development of many human malignancies including NSCLC, which is associated with reduced survival, frequent lymph node metastasis and poor chemo-radiation sensitivity47–51.